Inventor · disambiguated record
John Mark Ellard
Also filed as: ELLARD JOHN · ELLARD JOHN M · ELLARD JOHN MARK
12 granted patents·8 pending applications·42 citations·filing 2002–2023
88Inventor score
Files withTAKEDA PHARMACEUTICALS CO9SAREUM LTD3SHIRE HUMAN GENETIC THERAPIES3GENKYOTEX SUISSE SA2CUMMINS WILLIAM J1
Top patents by PatentIndex Score
20 records- 0195US11370803B2Heteroaryl plasma kallikrein inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 28, 2022·5 cites·17 claims
- 0294US11787796B2Plasma Kallikrein inhibitors and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Oct 17, 2023·4 cites·20 claims
- 0393US11352356B2Inhibitors of plasma kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 7, 2022·4 cites·29 claims
- 0492US10730874B2Inhibitors of plasma kallikrein and uses thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Granted Aug 4, 2020·7 cites·18 claims
- 0589US12065448B2Heteroaryl plasma kallikrein inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Aug 20, 2024·1 cites·19 claims
- 0682US8921544B2Oxazole tyrosine kinase inhibitorsSAREUM LTD·Filed 2014·Granted Dec 30, 2014·6 cites·14 claims
- 0782US8378095B2Oxazole tyrosine kinase inhibitorsSARUEM LTD·Filed 2008·Granted Feb 19, 2013·8 cites·14 claims
- 0879US9187465B2Oxazole tyrosine kinase inhibitorsSAREUM LTD·Filed 2014·Granted Nov 17, 2015·4 cites·8 claims
- 0976US10130619B2Amido thiadiazole derivatives as NADPH oxidase inhibitorsGENKYOTEX SUISSE SA·Filed 2015·Granted Nov 20, 2018·3 cites·12 claims
- 1073US12221441B2Plasma kallikrein inhibitors and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Feb 11, 2025·0 cites·19 claims
- 1171US12441724B2Inhibitors of plasma kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Oct 14, 2025·0 cites·29 claims
- 1259US2024199612A1Imidazopyridinyl inhibitors of plasma kallikreinSHIRE HUMAN GENETIC THERAPIES·Filed 2022·Application pending·0 cites
- 1358US2024199613A1Polycyclic inhibitors of plasma kallikreinTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1458US2024226106A1Inhibitors of plasma kallikreinSHIRE HUMAN GENETIC THERAPIES·Filed 2022·Application pending·0 cites
- 1554US2013102592A1Oxazole tyrosine kinase inhibitorsSAREUM LTD·Filed 2012·Application pending·0 cites
- 1654US2024382482A1Plasma kallikrein inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1754US2024228488A1Heteroaryl inhibitors of plasma kallikreinTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1846US2019046515A1Amido thiadiazole derivatives as nadph oxidase inhibitorsGENKYOTEX SUISSE SA·Filed 2018·Application pending·0 cites
- 1942US2004262585A1Use of dendrimers and poly-branched molecules to enhance signal in fluorescent assay systemsCUMMINS WILLIAM J·Filed 2002·Application pending·0 cites
- 2030US9079914B2Fused aminodihydro-oxazine derivativesELLARD JOHN MARK·Filed 2010·Granted Jul 14, 2015·0 cites·28 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →